The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Ipsen; Novartis; Perthera
Research Funding - Ipsen
Travel, Accommodations, Expenses - Halozyme
 
Sungjin Kim
No Relationships to Disclose
 
Mourad Tighiouart
No Relationships to Disclose
 
Emily Hautamaki
No Relationships to Disclose
 
Haesoo Kim
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Pfizer
 
Camille Ng
No Relationships to Disclose
 
Jar-Yee Liu
No Relationships to Disclose
 
Kevin S. Scher
No Relationships to Disclose
 
Samuel J Klempner
Stock and Other Ownership Interests - TP Therapeutics
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Bristol-Myers Squibb; Foundation Medicine; Lilly; Pieris Pharmaceuticals
Speakers' Bureau - Foundation Medicine
Research Funding - Astellas Pharma (Inst); Leap Therapeutics (Inst)
 
Veronica Placencio-Hickok
Patents, Royalties, Other Intellectual Property - Patent 17814046.3-1111 PCT/US2017037558. Bhowmick NA, Placencio V, Agarwal A., Smith B. Sensitization of tumors to therapies through endoglin antagonism (Inst)
 
Gillian Gresham
No Relationships to Disclose
 
Jun Gong
Honoraria - Amgen; Astellas Pharma; Clinical Congress Consultants
Consulting or Advisory Role - Amgen; Astellas Pharma; Clinical Congress Consultants